Description
An α-AR agonist; binds to α1A-, α1B-, α1D-, α2A-, α2B-, and α2C-ARs in a radioligand binding assay (IC50s = 0.08, 0.56, 0.45, 0.98, 1.8, and 0.22 μM, respectively); increases intracellular calcium levels in HEK293 cells transfected with human α2B-ARs (EC50 = 99 μM) but not other α-ARs; a 5-HT1 receptor agonist (Kis = 0.7 and 14 nM for the human 5-HT1D and 5-HT1B receptors, respectively); inhibits forskolin-induced cAMP production in CHO Pro 5 cells expressing human 5-HT1D and 5-HT1B receptors by 62 and 49%, respectively, at 1 μM; induces contraction of isolated dog nasal mucosal blood vessels at 0.25 μg/ml; reduces nasal patency in dogs when administered topically or intravenously
Formal name: 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-1H-imidazole, monohydrochloride
Synonyms:
Molecular weight: 280.8
CAS: 1218-35-5
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Immunology & Inflammation